Results 31 to 40 of about 4,243 (148)

Repeat hepatectomy for recurrent hepatocellular carcinoma

open access: yesJournal of British Surgery, 1996
Abstract This study evaluated the results of repeat hepatectomy for recurrent hepatocellular carcinoma (HCC) and delineated the limitations of such a treatment strategy. Of 290 patients who had radical hepatic resection, 167 had intrahepatic tumour recurrence. Fifty patients underwent a second hepatectomy.
N, Nagasue   +6 more
openaire   +2 more sources

Hepatic Epithelioid Hemangioendothelioma: Difficult Differential Diagnosis from Angiosarcoma

open access: yesCase Reports in Gastroenterology, 2020
Hepatic epithelioid hemangioendothelioma (EHE) is extremely rare, and preoperative diagnosis is difficult because hepatic EHE has clinicopathological features that are similar to those of angiosarcoma.
Tomohiko Taniai   +5 more
doaj   +1 more source

Repeat hepatectomy for recurrent colorectal metastases

open access: yesBritish Journal of Surgery, 2013
Abstract Background The oncological benefit of repeat hepatectomy for patients with recurrent colorectal metastases is not yet proven. This study assessed the value of repeat hepatectomy for these patients within current multidisciplinary treatment ...
D A, Wicherts   +8 more
openaire   +2 more sources

Evaluation of adhesion barrier types in a rat hepatectomy-induced adhesion model

open access: yesBMC Surgery, 2020
Background Adhesion formation after hepatectomy creates problems for repeat hepatectomy. This study aimed to compare the effectiveness of a spray (AdSpray) and sheet adhesion barrier (Seprafilm) in a rat hepatectomy-induced adhesion model. Methods Thirty
Atsushi Shimizu   +5 more
doaj   +1 more source

Preserving inferior right hepatic vein enabled bisegmentectomy 7 and 8 without venous congestion: a case report

open access: yesSurgical Case Reports, 2021
Background In hepatectomy, the preservation of portal perfusion and venous drainage in the remnant liver is important for securing postoperative hepatic function.
Masayoshi Terayama   +5 more
doaj   +1 more source

Radiofrequency ablation compared with repeat hepatectomy for patients with recurrent hepatocellular carcinoma: A meta-analysis

open access: yesJournal of Radiation Research and Applied Sciences, 2022
The therapy of recurrent hepatocellular carcinoma (RHCC) remains poorly defined. Repeat hepatectomy (RH) and radiofrequency ablation (RFA) have offered as alternative therapy choices.
Yi-gang Zhang   +6 more
doaj   +1 more source

Long-term survival after surgical resection for recurrent hepatic and pulmonary metastases of intrahepatic cholangiocarcinoma: a case report

open access: yesSurgical Case Reports, 2019
Background A few reports to date have described the effectiveness of surgical resection for recurrent intrahepatic cholangiocarcinoma (ICC). We report in this study a patient who achieved long-term survival after surgical resection for recurrent hepatic ...
Mihoko Yamada   +7 more
doaj   +1 more source

Repeat Hepatectomy for Breast Cancer Liver Metastases

open access: yesAnnals of Surgical Oncology, 2015
Resection of breast cancer liver metastases (BCLM) combined with systemic treatment is increasingly accepted as a therapeutic option; however, the potential benefit of repeat hepatectomy for recurrent BCLM is unknown.All consecutive female patients who underwent liver resection for BCLM at our center between January 1985 and December 2012 were included.
Ruiz, Aldrick   +10 more
openaire   +3 more sources

Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma

open access: yesWorld Journal of Surgical Oncology, 2023
Background and objective The recurrence occurs within 5 years in up to 70% of hepatocellular carcinoma (HCC) patients who received radical liver resection, and most patients are no longer suitable for repeat surgery.
Ze Zhang   +8 more
doaj   +1 more source

A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei

open access: yesSurgical Case Reports, 2021
Background For recurrent pseudomyxoma peritonei (PMP), repeat cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) can provide survival benefits if patients are carefully selected.
Kenya Yamanaka   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy